UCBB Net Margin

The Net Margin of US-China Biomedical Technology Inc (UCBB) is -175.00%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

UCBB Net Margin - Historical Value

Date	Value
2019-02-28	-175.00%
2018-02-28	-175.00%

UCBB Net Margin - Peers Comparison

Ticker	Name	Value
CBDT.CN	Empower Clinics Inc	-531.79%
CCM	Concord Medical Services Holdings Ltd	-103.72%
NLH.V	Nova Leap Health Corp	5.35%
XGN	Exagen Inc	-27.17%
BNYN	Banyan Corp	-109.59%
MBCN.TO	MindBeacon Holdings Inc	-97.32%
GNOW	American CareSource Holdings Inc	-132.77%
OCLG	Oncologix Tech Inc	-35.68%
PCHM	PharmChem Inc	22.69%
SPIN	Bitech Technologies Corp	-82.35%
AGHC	Aeon Global Health Corp	-61.67%
CTHZ	Cancer Treatment Holdings Inc	-2.14%
IDXG	Interpace Biosciences Inc	1.99%
MEDV.NE	Medivolve Inc	-49.40%
PMD	Psychemedics Corp	-18.80%
QMED	QMed Inc	-214.45%
CCEL	Cryo-Cell International Inc	1.26%
AIH	Aesthetic Medical International Holdings Group Ltd	-11.37%
CO	Global Cord Blood Corp	40.30%
GTMS.TO	Greenbrook TMS Inc	-47.42%
IOM.V	Assure Holdings Corp	-426.67%
NVOS	Novo Integrated Sciences Inc	-121.61%
PDH.V	Premier Diversified Holdings Inc	-24944.91%
BBAL	New York Health Care Inc	-2.37%
FCHS	First Choice Healthcare Solutions Inc	-27246.51%
FPCG	Avem Health Partners Inc	29.77%
NPTH.V	NeuPath Health Inc	-1.00%